Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Clinical trial NCT02725489 · COMPLETED

Trial details

NCT number: NCT02725489
Sponsor: Mary Crowley Medical Research Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma Uterine Cancer Cervical Cancer Endometrial Cancer

Start date: 2016-06-03
Primary completion: 2019-12-30
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.